BIODESIX INC - Common Stock, par value $0.001 per share (BDSX)
CUSIP: 09075X207
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 9,724,771
- Total 13F shares
- 2,402,450
- Share change
- +1,254,683
- Total reported value
- $34,835,141
- Price per share
- $14.50
- Number of holders
- 21
- Value change
- +$19,176,567
- Number of buys
- 12
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 09075X207?
CUSIP 09075X207 identifies BDSX - BIODESIX INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 09075X207:
Top shareholders of BDSX - BIODESIX INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Jack W. Schuler |
3/4/5
13D/G
|
Emeritus Director, 10%+ Owner · SCHULER JACK W |
24%
from 13D/G
|
2,313,210
|
$23,551,330 | +$4,900,921 | 23 Jan 2026 | |
| Orin Hirschman |
13D/G
|
— |
7.7%
|
758,328
|
$5,156,630 | $0 | 31 Mar 2026 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
|
Company |
5.1%
|
7,673,880
|
$4,374,112 | +$570,000 | 12 May 2025 | |
| Telemark Asset Management, LLC |
13D/G
13F
|
Company |
5.4%
|
427,824
|
$2,909,460 | +$680,060 | 22 Jan 2026 | |
| Soleus Capital Master Fund, L.P. |
13D/G
|
— |
4.1%
|
416,599
|
$2,832,873 | $0 | 31 Mar 2026 | |
| John Patience |
3/4/5
|
Director, Chairman |
—
mixed-class rows
|
386,251
mixed-class rows
|
$2,555,541 | — | 31 Mar 2026 | |
| Birchview Capital, LP |
13F
|
Company |
2.8%
|
286,804
|
$1,950,267 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
2.7%
|
262,425
|
$1,784,490 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
192,138
|
$1,306,538 | — | 31 Dec 2025 | |
| Scott Hutton |
3/4/5
|
President & CEO, Director |
—
mixed-class rows
|
160,298
mixed-class rows
|
$981,155 | -$65,840 | 20 Feb 2026 | |
| Monashee Investment Management LLC |
13F
|
Company |
1.2%
|
112,344
|
$763,939 | — | 31 Dec 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.66%
|
64,483
|
$438,000 | — | 31 Dec 2025 | |
| Charles M. Watts |
3/4/5
|
Director |
—
mixed-class rows
|
458,755
mixed-class rows
|
$389,740 | — | 31 Mar 2025 | |
| Robin Harper Cowie |
3/4/5
|
CFO, Sec'y & Treasurer |
—
mixed-class rows
|
49,637
mixed-class rows
|
$315,954 | -$19,545 | 20 Feb 2026 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.46%
|
44,783
|
$304,524 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.44%
|
42,453
|
$288,753 | — | 31 Dec 2025 | |
| Gary Anthony Pestano |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
40,941
mixed-class rows
|
$245,279 | -$15,336 | 20 Feb 2026 | |
| Kieran O'Kane |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
41,225
mixed-class rows
|
$234,037 | -$15,541 | 20 Feb 2026 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.34%
|
33,017
|
$224,516 | — | 31 Dec 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.28%
|
27,542
|
$187,286 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.27%
|
25,985
|
$176,698 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.25%
|
24,466
|
$166,369 | — | 31 Dec 2025 | |
| Hany Massarany |
3/4/5
|
Director |
—
mixed-class rows
|
377,337
mixed-class rows
|
$133,092 | — | 02 Jan 2026 | |
| STATE STREET CORP |
13F
|
Company |
0.18%
|
17,802
|
$121,054 | — | 31 Dec 2025 | |
| Shay Capital LLC |
13F
|
Company |
0.17%
|
16,145
|
$109,786 | — | 31 Dec 2025 | |
| DRW Securities, LLC |
13F
|
Company |
0.16%
|
15,372
|
$104,529 | — | 31 Dec 2025 | |
| Jean M. Franchi |
3/4/5
|
Director |
—
mixed-class rows
|
122,658
mixed-class rows
|
$99,943 | — | 02 Jan 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
11,134
|
$75,711 | — | 31 Dec 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.1%
|
10,000
|
$68,000 | — | 31 Dec 2025 | |
| Chris Vazquez |
3/4/5
|
Chief Accounting Officer |
—
mixed-class rows
|
15,275
mixed-class rows
|
$61,897 | -$4,585 | 20 Feb 2026 | |
| Ryan H. Siurek |
3/4/5
|
Chief Accounting Officer |
—
mixed-class rows
|
43,825
mixed-class rows
|
$53,711 | — | 08 May 2023 | |
| Robert William Georgantas III |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
38,214
|
$46,836 | — | 21 Nov 2022 | |
| Allworth Financial LP |
13F
|
Company |
0.05%
|
4,965
|
$33,762 | — | 31 Dec 2025 | |
| Matthew W. Strobeck |
3/4/5
|
Director |
—
mixed-class rows
|
13,158
mixed-class rows
|
$22,565 | — | 02 Jan 2026 | |
| Jon Faiz Kayyem |
3/4/5
|
Director |
—
mixed-class rows
|
11,797
mixed-class rows
|
$19,608 | — | 02 Jan 2026 | |
| Lawrence T. Kennedy Jr. |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
11,797
mixed-class rows
|
$19,608 | — | 02 Jan 2026 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
193
|
$1,312 | — | 31 Dec 2025 | |
| Quattro Advisors LLC |
13F
|
Company |
0%
|
187
|
$1,272 | — | 31 Dec 2025 | |
| Fortitude Family Office, LLC |
13F
|
Company |
0%
|
171
|
$1,163 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
143
|
$972 | — | 31 Dec 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
100
|
$680 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
61
|
$415 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
1
|
$7 | — | 31 Dec 2025 |
Institutional Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q1 2026
As of 31 Mar 2026,
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,402,450 shares.
The largest 10 holders included
AIGH Capital Management LLC, Telemark Asset Management, LLC, Aberdeen Group plc, VANGUARD CAPITAL MANAGEMENT LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, PERKINS CAPITAL MANAGEMENT INC, SEI INVESTMENTS CO, GSA CAPITAL PARTNERS LLP, UBS Group AG, and VANGUARD FIDUCIARY TRUST CO.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
25
Q1 2026 holders
21
Holder diff
-4
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.